As per reports, Apple Inc. (AAPL) is preparing to allow alternative app stores on its iPhones and iPads in the European Union as soon as late next year to comply with a new European competition law it had fought. The iPhone maker had raised that allowing sideloading, bypassing its App Store, exposes users to security and privacy dangers. The inclusion of outside app stores poses a major threat, also rivals would first have to convince consumers to leave the security and simplicity of using Apple’s own store. The impact of consequences depends on how the U.S. company complies with additional mandates in the European law, known as the Digital Markets Act.
As per the new regulation, Apple customers can install apps without using the company’s App Store, however, the iPhone giant has yet to decide on whether to comply with other provisions of the law, such as alternative payment systems to its own. Allowing its payment tool to be skipped poses a loss of billions of dollars in revenue that the company earns by charging a commission of up to 30% on App Store purchases.
Dow 30 component Apple (AAPL) revolutionized personal technology with the introduction of the Macintosh in 1984. Today Apple leads the world in innovation with iPhone, iPad, Mac, Apple Watch, and Apple TV. Apple’s four software platforms — iOS, macOS, watchOS, and tvOS — provide seamless experiences across all Apple devices and empower people with breakthrough services including the App Store, Apple Music, Apple Pay, and iCloud. Apple’s more than 100,000 employees are dedicated to making the best products on earth, and to “leaving the world better than they found it. To learn more about Apple (AAPL) and track its ongoing progress at Vista Partners Apple (AAPL), Coverage Page.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.
DID YOU KNOW?
The current fertility rate for Europe in 2022 is 1.610 births per woman.
If you have ever struggled with infertility issues, or know someone who has, you are probably well aware of how demoralizing it can be. Imagine for a moment spending thousands of dollars and months of intensive medical procedure only to end up empty handed, exhausted, sad, and defeated because after all of that time, work, and money, you still don’t have a baby. That’s an incredibly difficult situation, and it’s becoming more common each passing year. Likewise, the need for more effective, less invasive infertility treatment options is increasing with each passing year. This is the sole focus of medtech company INVO Bioscience (NASDAQ: INVO). Learn more by reading the following story that we published recently.